BAKER BROS. ADVISORS LP

Holdings History for Revolution Medicines, Inc. - Common Stock, par value $0.0001 per share (RVMD)

Symbol: RVMD on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 9,455,357 shares
Security Ownership %: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Baker Bros. Advisors LP ownership in Revolution Medicines, Inc. Common Stock, par value $0.0001 per share (RVMD)

17 Feb 2026 - Baker Bros. Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9,455,357 shares of Revolution Medicines, Inc. Common Stock, par value $0.0001 per share (RVMD). This represents 4.9% ownership of the company. In their previous filing dated 14 Aug 2025, BAKER BROS. ADVISORS LP had reported owning 9,364,972 shares, indicating an increase of +0.97%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Baker Bros. Advisors LP	4.9%	-2%	$971,159,717	9,455,357	+90,385	+0.97%	$102.71	13G/A	31 Dec 2025	17 Feb 2026, 16:19
Baker Bros. Advisors LP	5%		$360,551,422	9,364,972			$38.50	13G	30 Jun 2025	14 Aug 2025, 16:26

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	4.4%	0%	$753,119,185	9,455,357	0		$79.65	Q4 2025
30 Sep 2025	3.2%	+0.03%	$441,565,172	9,455,357	+90,385	+0.97%	$46.70	Q3 2025
30 Jun 2025	3.3%	+0.51%	$344,537,320	9,364,972	+1,428,000	+18%	$36.79	Q2 2025
31 Mar 2025	3.1%	0%	$280,651,330	7,936,972	0		$35.36	Q1 2025
31 Dec 2024	3.7%	+0.17%	$347,163,155	7,936,972	+367,882	+4.9%	$43.74	Q4 2024
30 Sep 2024	3.6%	0%	$343,258,232	7,569,090	0		$45.35	Q3 2024
30 Jun 2024	3.8%	+0.01%	$293,756,383	7,569,090	+19,841	+0.26%	$38.81	Q2 2024
31 Mar 2024	3.1%	+0.97%	$243,312,295	7,549,249	+2,400,592	+47%	$32.23	Q1 2024
31 Dec 2023	1.7%	+0.8%	$147,663,483	5,148,657	+2,457,164	+91%	$28.68	Q4 2023
30 Sep 2023	0.43%	0%	$74,500,526	2,691,493	0		$27.68	Q3 2023
30 Jun 2023	0.42%	0%	$71,997,438	2,691,493	0		$26.75	Q2 2023
31 Mar 2023	0.32%	+0.29%	$58,297,738	2,691,493	+2,469,271	+1111%	$21.66	Q1 2023
31 Dec 2022	0.03%	0%	$5,293,328	222,222	0		$23.82	Q4 2022
30 Sep 2022	0.03%	0%	$4,382,000	222,222	0		$19.72	Q3 2022
30 Jun 2022	0.02%	0%	$4,331,000	222,222	0		$19.49	Q2 2022
31 Mar 2022	0.03%	0%	$5,669,000	222,222	0		$25.51	Q1 2022
31 Dec 2021	0.03%	0%	$5,593,000	222,222	0		$25.17	Q4 2021
30 Sep 2021	0.03%	0%	$6,113,000	222,222	0		$27.51	Q3 2021
30 Jun 2021	0.03%	0%	$7,053,000	222,222	0		$31.74	Q2 2021
31 Mar 2021	0.04%	+0.04%	$10,196,000	222,222	+222,222	NEW	$45.88	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.